Yao Huang,1,2 Jianxing Zeng,2 Teng Liu,2 Qingyi Xu,2 Xianglin Song,2 Jinhua Zeng1,2 1Department of Hepatobiliary Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People’s Republic of China; 2Department of Hepatic
Huang Y +5 more
doaj
Background & Aims: High-dose unilobar radioembolization, or ‘radiation lobectomy’ (RL), is an induction therapy that achieves contralateral future liver remnant hypertrophy while simultaneously irradiating the tumor.
Daan Andel +9 more
doaj +1 more source
Liver cancer, primarily hepatocellular carcinoma (HCC), is the second leading cause of cancer-related deaths globally. It is typically characterized by rapid progression, poor prognosis, and high mortality rates.
Alireza Tojjari +4 more
doaj +1 more source
The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma
Yuping He,1,2,* Minghao Xu,2,3,* Chenhao Zhou,2,3 Qiongzhu Dong,2,4 Zhiqiu Hu,2,4,5 Ning Ren2– 4 1School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, 200093, People’s Republic of China; 2Key ...
He Y, Xu M, Zhou C, Dong Q, Hu Z, Ren N
doaj
First-Line Treatment for Advanced Hepatocellular Carcinoma: A Three-Armed Real-World Comparison
Robert Mahn,1,* Oscar André Glüer,1,* Farsaneh Sadeghlar,1 Christian Möhring,1 Taotao Zhou,1 Thomas Anhalt,1 Malte Benedikt Monin,1 Alexander Kania,2 Tim R Glowka,2 Georg Feldmann,3 Peter Brossart,3 Joerg C Kalff,2 Ingo GH Schmidt-Wolf,4 ...
Mahn R +14 more
doaj
Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on “Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging” [PDF]
Abdelrahman M Attia +2 more
doaj +1 more source
Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma: Editorial on “Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma” [PDF]
Valerie Chew
doaj +1 more source
Distinct immune signatures define hepatitis D- versus hepatitis B-associated hepatocellular carcinoma. [PDF]
Glimmann S +8 more
europepmc +1 more source
Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma. [PDF]
Wu L +6 more
europepmc +1 more source
Identification and credentialing of patient-derived xenograft models of invasive lobular carcinoma
Jagmohan Hooda +12 more
doaj +1 more source

